Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accredited, accreted, ADPKD, AKPKD, allotted, annum, answer, arm, artificially, asymptomatic, autosomal, bid, biopsy, borrow, borrowed, bulletin, burdensome, cholestatic, Codification, complaint, consecutive, curative, cure, DAA, default, delisted, delisting, dissolution, District, dominant, downstream, encumber, ESRD, expert, exposure, fatty, floating, genomic, genotype, Hagan, hepatic, hepatotoxicity, hepatoxicity, HERA, Hy, hyperbilirubinemia, IIa, IIb, imbalance, Imputation, inventory, issuable, jaundice, Joseph, Journal, knee, LAI, lawsuit, lend, lender, LIBOR, lift, lifted, light, loan, MAD, mark, media, mid, misleading, mRNA, multi, NAFLD, obsolescence, OTC, outsourced, Oxford, parallel, Pink, PK, plaintiff, polycystic, prepaid, prepay, prepayment, proof, quotation, randomized, reconciling, reconsidering, regain, release, reorganization, respiratory, retrospective, SAE, Southern, step, sublease, sublet, Topic, transient, underway, unlisted, unspecified, unused, upper, usage, variable, verbal, vigorously, virologic, visit, Zurich
Removed:
adjust, behave, biomarker, BLA, bodily, bond, comparable, concurrent, constitutionality, construct, denominator, division, Equally, expiring, idec, inflammatory, instrumental, interact, investigative, John, losing, MA, Map, memorialize, mutual, mutually, newly, numerator, package, payback, percent, Pharma, PPACA, presumption, profile, prospectively, represented, simultaneously, spread, stipulated, straight, Suite, Supreme, transformative, unclear, upheld, validate, weighting
Filing tables
Filing exhibits
Related press release
RGLS similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 Nos. 333-194293 and 333-203292) of Regulus Therapeutics Inc., and
(2) Registration Statement (Form S-8 Nos. 333-184324, 333-188606, 333-194294, 333-201988 and 333-206511, 333-209654 and 333-215793) pertaining to the 2009 Equity Incentive Plan, 2012 Equity Incentive Plan, 2012 Employee Stock Purchase Plan and Inducement Plan of Regulus Therapeutics Inc.;
of our report dated March 2, 2017, with respect to the financial statements of Regulus Therapeutics Inc. included in this Annual Report (Form 10-K) of Regulus Therapeutics Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
San Diego, California
March 2, 2017